ClinicalTrials.gg
RecruitingNCT07244276Updated Nov 24, 2025

Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery

An interventional study of Compression continuous suture with suture crimping and Conventional Suture with suture crimping in Primary Pterygium, sponsored by Tianjin Eye Hospital. Recruiting at 1 site in China. Open to participants aged 30 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-24.

Sponsored by Tianjin Eye Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 4 months after the study started (first participant enrolled Apr 2024, registered Aug 2025).
  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
30 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Pterygium with a site in China — 2 open to participants now, 4 under way, 1 of them phase 3. Pterygium · China.

Planned enrollment
16th of 20
40 · median 60
Started
2024
the only one that year
No phase
13 of 23
1 open now
Registered
22nd of 23
by date

Among the 23 studies in Pterygium with a site in China, this one is the 16th largest by planned enrollment of the 20 interventional ones that give a count, is the only one that started in 2024, is one of 13 with no phase, and was the 22nd registered.

Pterygium

109 studies on the registry are indexed under Pterygium; 9 are open to participants now.

Browse Pterygium studies →

Open to participants now

2 of the 23 studies in Pterygium with a site in China are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 3 Pterygium studies recruiting now, 2 set no upper age limit and 1 stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 30 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Pterygium with a site in China, or all of them as a file.
02

Study summary

To compare the advantages and disadvantages of continuous suture with suture and conventional Suture in primary pterygium surgery for autologous conjunctival graft fixation

Read the detailed description

Pterygium is an abnormal fibrovascular tissue hyperplasia disease that occurs in the conjunctiva. The pterygium tissue can break through the limbus of the corneosclera and grow into the cornea, causing a foreign body sensation in the eyes, astigmatism, decreased vision, and even restricted eye movement. The purpose of surgical treatment for pterygium is not only to remove the diseased tissue, but more importantly, to reduce the recurrence of pterygium after surgery. Pterygium excision combined with simple autologous conjunctival transplantation is currently the most commonly used method for treating pterygium. The recurrence rate after autologous conjunctival epithelial tissue transplantation can be reduced to 5% to 30%.

As heterogenic substances, sutures can irritate the ocular surface, aggravate postoperative inflammatory reactions and conjunctival edema or hemorrhage, delay the repair of corneal wound epithelium, lead to abnormal ocular surface function, intensify postoperative discomfort, and induce hypertrophic granuloma or cysts, etc. Moreover, these adverse reactions can also induce the recurrence of pterygium (0-26%). In addition, the longer the time interval between suture removal, The greater the difficulty of removal, the more likely some of the knots may be completely buried under the conjunctiva. Therefore, in order to alleviate the adverse reactions caused by sutures and further simplify the operation of pterygium excision surgery, many attempts have been made at home and abroad to improve and innovate the method of graft fixation.

03

Conditions studied

  • Primary Pterygium

Browse trials for

Keywords

  • Primary Pterygium
  • Compression Continuous Suture
  • Conventional Suture
04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of primary pterygium according to diagnostic criteria;
  2. The pterygium head invades the cornea by 2-5mm;
  3. The patient agrees to the surgical treatment and signs the surgical consent form.

Exclusion criteria

Exclusion Criteria:

  1. History of previous eye surgery;
  2. Have active ocular inflammatory lesions;
  3. recurrent and pseudopterygium;
  4. The patient refuses surgery or is unable to have regular follow-ups
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Other
    Continuous suture group

    Pterygium excision combined with autologous conjunctival transplantation was performed

    Procedure: Compression continuous suture with suture crimping

  • Other
    Intermittent suture group

    Pterygium excision combined with autologous conjunctival transplantation was performed

    Procedure: Conventional Suture with suture crimping

Interventions

  • ProcedureCompression continuous suture with suture crimping

    Pterygium excision combined with autologous conjunctival transplantation was performed, and the continuous suture method with pressure lines was adopted during the operation

  • ProcedureConventional Suture with suture crimping

    Pterygium excision combined with autologous conjunctival transplantation was performed, and the traditional suture method was adopted during the operation

06

What researchers measure

Primary outcomes

  1. Duration of surgery

    The date on which the surgery was performed

    Time frame: Intraoperative

  2. Implant stability

    Whether the conjunctival graft is loose or detached

    Time frame: Postoperative follow-up was performed 1 day and 1 week after surgery

  3. Postoperative discomfort

    The degree of discomfort after surgery was evaluated using the VAS Pain score Scale

    Time frame: Postoperative follow-up was performed 1 day and 1 week after surgery

  4. Stitch removal time

    The date when the stitches were removed

    Time frame: Postoperative follow-up was performed 1 week after surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Apr 2026, 24 months after the start.

Of 18 interventional studies with no phase under Pterygium, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 28. This study's planned 24 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 8, 2025
First posted
Nov 24, 2025
StartActual
Apr 2, 2024
Primary completionEst.
Apr 2, 2026
CompletionEst.
Jul 2, 2026
Last update
Nov 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07244276
Lead sponsor
Tianjin Eye Hospital
Responsible party
Sponsor
First posted
Nov 24, 2025
Start date
Apr 2, 2024
Primary completion
Apr 2, 2026 (estimated)
Completion
Jul 2, 2026 (estimated)
Last update
Nov 24, 2025

Study contacts

Yan Wang, director
Contact
wangyan7143@vip.sina.com
23187165 ext. +86 022
Yi Zhang
study director · Tianjin Eye Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion